Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line

Cisplatin (CDDP) is one of the most active drugs to treat nasopharyngeal carcinoma (NPC) patients. To further understand the mechanisms of CDDP-resistance in NPC, two CDDP-resistant sublines (CNE2-CDDP and CNE2-CDDP-5Fu) derived from parental NPC cell line CNE2 were established. It was found that at...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Si Ming, Fang, Wei Yi, Liu, Teng Fei, Yao, Kai Tai, Zhong, Xue Yun
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902222/
https://www.ncbi.nlm.nih.gov/pubmed/20628484
http://dx.doi.org/10.1155/2010/915046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902222/
https://www.ncbi.nlm.nih.gov/pubmed/20628484
http://dx.doi.org/10.1155/2010/915046

Ejemplares similares